|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Clopidogrel#Contraindications]] |
| {{Clopidogrel}}
| |
| {{CMG}}; {{AE}} {{JH}}
| |
| | |
| ==Contraindications==
| |
| | |
| ====4.1 Active Bleeding====
| |
| | |
| Plavix is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage.
| |
| | |
| ====4.2 Hypersensitivity====
| |
| | |
| Plavix is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see Adverse Reactions (6.2)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB/SANOFI PHARMACEUTICALS PARTNERSHIP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01b14603-8f29-4fa3-8d7e-9d523f802e0b | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |